• Study investigates PrEP use, preference in naive adults

    4 days ago - By Healio

    Researchers evaluating new PrEP use among previously PrEP-naive patients found that patients dispensed tenofovir alafenamide had more dispenses and were less likely to switch or discontinue treatment compared with those dispensed emtricitabine/tenofovir disoproxil fumarate.
    The study, which was presented at ID Week 2022, assessed the use of emtricitabine/tenofovir disoproxil fumarate and tenofovir alafenamide among PrEP-naive adults.
    “In this study, we evaluated the utilization of F/TDF and F/TAF based PrEP-naive patients after the approval of F/TAF for PrEP in the United
    Read more ...